Abstract Serotonin receptor 1A and 2A positive cells in postmortem brainstems were demonstrated via immunohistochemistry in eight control age-matched elderly individuals and eight Alzheimer patients. The 5-HT1A positive cells were found in substantia nigra, pontile nucleus, and vagal as well as dorsal raphe nucleus, while 5-HT2A receptor positive cells were found in motor, sensory and spinal trigeminal nuclei, pontile nucleus, substantia nigra, and nucleus solitarius. A comparison in density of positive cells per unit area was made between control agematched and Alzheimer individuals. Statistically significant differences (p≤0.01) in density were observed in 5-HT1A cells in pontile, dorsal raphe, and vagal nuclei between control age-matched and Alzheimer, and in 5-HT2A positive cells in the sensory trigeminal nucleus, between control and Alzheimer. This de novo study indicated the presence of 5-HT1A
Introduction
Serotonin (5-hydroxytryptamine 5-HT) has a wide range of neurological functions (Banerjee et al. 2007 ; Kroeze et al. 2002) and is mediated by seven receptors (Saxena 1995) termed 5-HT1, 5-HT2, 5-HT3, 5-HT4, 5-HT5, 5-HT6, and 5-HT7. 5-HT1 class is subdivided into 1A, 1B, 1C, and 1D (Hoyer et al. 1994; Kroeze et al. 2002) . The serotonin receptors or 5-HT receptors consist of a group of G-protein-coupled receptors and ligand gate ion channels, which exist in both the CNS and PNS. Except for 5-HT3, which is a ligand-gated ion channel, all others are G-protein-coupled receptors that need a second messenger to work (Hoyer et al. 1994; Frazer and Hensler 1999) . Among these proteins, 5-HT1A and 5-HT2A appear to have a great effect on the major functions of the central nervous system (Lorke et al. 2006; Müller et al. 2007; Wesołowska 2002) .
5-HT1A and 5-HT2A receptors are of interest in the pathology of several psychiatric disorders, such as anxiety and depression (Kroeze et al. 2002; Raote et al. 2007; Saxena 1995) . 5-HT2A receptors are present in many regions of the human cortex (Lorke et al. 2006; Wai et al. 2008 ). Both 5-HT1A and 5-HT2A receptors have been associated with symptoms and cognitive disturbances in a wide range of psychoses, including schizophrenia (Sumiyoshi et al. 2008 ). Functionally, it is possible these receptors might act through other neurotransmitters, e.g., dopamine, acetylcholine, glutamine, and gamma-aminobutyric acid (GABA) (Sumiyoshi et al. 2008) . Pathologically, 5-HT2A receptor upregulation has recently been documented in postmortem brain tissue of depressed patients in comparison with control and has correlated inversely with protein kinase A activities of the specimens (Shelton et al. 2009 ). In the brainstem, Hall et al. (1997) used labeling to report limited binding of 5-HT1A and 5-HT2A receptors. However, using a range of techniques, other studies have demonstrated 5-HT1A and 5-HT2A receptor binding sites in brainstems in general (Burnet et al. 1995) and have shown that 5-HT1A and 5-HT2A are important for both normal function and abnormal malfunction of the brainstem (Kroeze et al. 2002; Saxena 1995) . The working hypothesis is that the brainstem of the human may be modulated by serotonin receptors. To prove this hypothesis in our study, the widely studied 5-HT1A and 5-HT2A nervous system receptors were used as markers to decipher possible serotonin receptor involvement in specific nuclei of the brainstem.
Materials and methods
The brainstems of eight normal aging specimens (age 63-93, mean=83.4) and eight age-matched Alzheimer cases (age 69-94, mean=83.3) were used. Specimens were obtained from aged homes and hospitals of Guangzhou, China, with consent from the family, the aged homes, and/or hospitals involved. The project was approved by the ethics committee of the Chinese University of Hong Kong (CUHK). The Alzheimer patients were clinically diagnosed by DSM-IV as senile dementia of the Alzheimer type (stages IV and V of Braak's scale), and the diagnosis was confirmed by the presence of plaques and tangles in their corresponding pathological specimens. The midbrain, pons, and medulla of each individual of the two groups were separated and fixed in 4% paraformaldehyde, 1 to 6 h after death. They were then processed in graded alcohol followed by xylene clearing and then embedded in paraffin. Sections of 6 μm were cut from the specimen. For each specimen from each individual, five sections, each of 200 μm apart, were selected. Immunohistochemistry of 5-HT1A and 5-HT2A was performed. The antibodies for 5-HT1A and 5-HT2A were purchased from Santa Cruz Biotechnology (sc1459; Santa Cruz, CA, USA) and Abcam (ab16028; Cambridge, UK), respectively. The sections were then incubated with primary antibodies against 5-HT1A (1:500) and 5-HT2A (1:500). After washing three times with phosphate buffered saline (PBS), the sections were subsequently incubated with biotinylated anti-goat IgG antibody (5-HT1A) (1:500) and anti-rabbit IgG antibody (5-HT2A) (1:500) and then reacted with ABC reagents (PK 6101, Vector Laboratories, CA, USA). The resulting sections were finally observed under a photomicroscope (Axioplan 2 Photomicroscope, Zeiss, Germany). The positive reactive cells were brown in color, and some slides were counterstained with cresyl violet for our study. For comparison of density, five random fields from each of the five sections per individual at ×200 were chosen from each individual of both groups. The following regions were used for 5-HT1A positive cells counting: substantia nigra, pontile, dorsal raphe nucleus, and vagal nucleus. The substantia nigra, sensory trigeminal nucleus, and solitary nucleus were selected for 5-HT2A positive cells counting. These regions represented the major collections of positive 5-HT1A or 5-HT2A cells and were therefore selected. Identification and selection of these regions were performed according to Brodal (1981) .
Statistical analysis
Mean±standard error was computed for 30 total fields in each region of each individual of both control and Alzheimer groups. Statistical analysis was done using SPSS 13.0 software. The data were submitted to one-way ANOVA followed by the Scheffe's method for multiple comparisons. Mean and standard deviation were computed for each group. P≤0.01 was assigned as statistically significant.
Colocalization
Five random sections (each of 6 μm) from all brainstem regions of each individual from both groups of normal and Alzheimer patients were selected for colocalization. The tissue sections were first immersed in PBS with 0.1% Trition X-100 for 10 min, rinsed with PBS, incubated with 3% hydrogen peroxide (H 2 O 2 ) in absolute methanol for 30 min, and then rinsed again. Bovine serum albumin (BSA) of 0.1% was used as non-specific antigen blocking solution. After blocking with 0.1% BSA for 1 h, the sections were incubated either with diluted polyclonal antibody 5HT1A (1:200; sc1459; Santa Cruz Biotechnology Inc.) or diluted 5HT2A (1:200; ab16028; Abcam Inc.) overnight at 4°C. On the next day, the sections were rinsed with PBS and incubated in corresponding diluted biotinylated secondary antibody (1:200; Zymed Laboratories, Inc., San Francisco, CA, USA) for 2 h. The sections were then rinsed and incubated in diluted streptavidin-HRP (horseradish peroxidise) conjugated solution (1:200; Zymed Laboratories, Inc.) for 2 h, then the first color was developed with Vector VIP Substrate Kit (Vector Laboratories). Subsequently, the tissue sections were rinsed with PBS and incubated in 0.1% BSA again for 1 h. The second primary polyclonal antibody, either diluted cholinacetyltransferase (ChAT, 1:200; ab68779; Abcam Inc.), TH (tyrosine hydroxylase 1:200; sc1459; Santa Cruz Biotechnology Inc.), GABA (1:200; ab65269; Abcam Inc.), or serotonin (1:200; ab10385; Abcam Inc.) was added and incubated overnight at 4°C. After rinsing with PBS, the sections had 2-h incubation with the corresponding biotinylated secondary antibody (1:200; Zymed Laboratories, Inc.). The tissue sections were then rinsed, followed by 2-h incubation in dilute streptavidin-HRP conjugated solution (1:200; Zymed Laboratories, Inc.). The second color was developed with vector DAB Substrate Kit (Vector Laboratories), and the sections were dehydrated and mounted. Tissue sections for negative control were processed similarly but without the first and secondary primary antibodies added.
Results
In the normal control aged, serotonin 1A receptor positive cells were observed in the periaqueductal gray of the midbrain (Fig. 1a-c) . The superior colliculus displayed few 5-HT1A positive cells (Fig. 2 ). Significant amounts of 5-HT1A receptor positive cells were demonstrated in the substantia nigra (Fig. 3a) , and while no positive cells were seen in the red nucleus, there were many positive 5-HT1A fibers (Fig. 3a, b) . In the pons, pontile nuclei had many 1A receptor positive cells (Fig. 4a) . High magnification revealed that the majority of the positive sites were in the soma of the cells (Fig. 4b) . In the medulla, the hypoglossal nucleus displayed very few 1A receptor positive cells, while some 1A receptor positive cells were seen in the dorsal vagal nucleus (Fig. 5a ). The midline regions of the brainstem, e.g., the dorsal raphe nucleus, had scattered 1A receptor positive cells (Fig. 5b, c) , while the inferior olive had almost no 1A receptor positive cells (Fig. 5d) .
In the normal aged, the 2A receptor positive cells again appeared in the periaqueductal region of the midbrain (Fig. 6a, b ). There were no 5-HT2A positive cells in the red nucleus, but there were a few positive cells in the substantia nigra (Fig. 6c) . In the pons, some 2A receptors positive cells were seen in the pontile nuclei (Fig. 6d ). There were also 2A receptor positive cells in the motor, sensory, and spinal trigeminal nuclei (Fig. 6e, f) , while no positive 5-HT2A cells were seen in the floor of the IV ventricle (the hypoglossal and vagal nuclei) (Fig. 6g) . The solitary nucleus in the medulla exhibited some 2A receptor positive cells (Fig. 7a, b) . No 2A receptor positive cell was observed in the inferior olive (Fig. 7a) , but positive 5-HT2A cells were demonstrated in the dorsal raphe and the other parts of the reticular formation (Fig. 7a) .
Colocalization was performed between 5-HT1A and 5-HT2A with cholinergic neurons (using ChAT as a marker), dopaminergic neurons (using tyrosine hydroxylase as a marker), GABA neurons (using GABA as a marker), and serotonin neurons (using serotonin as a marker). To date, we have observed only colocalization of 5-HT1A receptors on cholinergic neurons (Fig. 8a, b) and GABA positive fibers ending on 5-HT2A neurons (Fig. 8c) . Comparison of the densities of 1A and 2A receptor positive cells in the different brainstem regions between normal age-matched and Alzheimer patients were computed (Fig. 11) . The statistical difference (p<0.01) was particularly significant in 1A receptors of the pontile nuclei, dorsal raphe nuclei, and vagal nuclei. For 2A receptor positive cells, the difference (p < 0.01) was significant only for the sensory trigeminal nuclei. For the substantia nigra and the nucleus solitarius, differences in the density of 2A receptor positive cells were not significant between control age-matched and Alzheimer brainstems.
Discussion
Our results revealed the extensive localization of the serotonergic 1A and 2A receptor positive cells inside the human brainstem and therefore inferred the involvement of these serotonin receptors in the functioning of many nuclei in the brainstem. There was also a general decrease of these positive cells in all the nuclei selected for study in Alzheimer patients, with the exception of the substantia nigra. These findings in the human are de novo information and 
and brown (5-HT1A immunoreaction) (DAB) sites, while a is not counterstained and only shows brown reaction sites must be kept in mind in future therapeutic studies with serotonin-related psychiatric drugs that will also influence the brainstem. Further, serotonin 1A receptor positive cells were located only in substantia nigra, pontile, dorsal raphe, and vagal nuclei. It is unknown at this time whether this phenomenon was related to a general loss of neurons in Alzheimer disease or to specific loss of particular groups of neurons, such as those of the cortex (Li et al. 1997; Lorke et al. 2006; Yew et al. 1999a, b) . 5-HT1A and 5-HT2A positive cells have been documented to exist in the dorsal raphe nucleus in animals via pharmacological studies (Curran Freitas et al. 2008 ) and in humans with PET scans (Lundberg et al. 2007 ). Using immunohistochemistry, our study verified the results of Lundberg et al. (2007) showing 5-HT1A receptor positive cells in the dorsal raphe of the human. We, however, could not see any significant amount of 5-HT2A positive cells in the same human nucleus as reported in animals (Freitas et al. 2008 ). The function of both 5-HT receptor positive cells in this study may be involved with antinociception (Freitas et al. 2008) ; their roles in behavior anxiety and depression have been illustrated by others (Delgado et al. 2005; Lira et al. 2003) . 5-HT1A and 2A positive cells in the dorsal raphe might also control sleep and thus have an important relationship in depression (Ulak et al. 2010 ).
Serotonin immunoreactive neurons have been reported in the trigeminal nucleus of mammals (Lazarov 2002) . This study has pinpointed the localization of serotonin 2A receptor cells in the same nucleus, suggesting specific serotonergic modulation or function in the trigeminal complex. In addition, presence of 5-HT1A receptor positive cells in the vagal nucleus and 5-HT2A receptor positive cells in the solitary nucleus indicates the role of these receptor positive cells in internal regulation of the viscera, as in cardiac control (Jordan 2005) , baroreceptor reflex (Raul 2003) , and respiration (Ozawa and Okado 2002) . Serotonin 1A and 2A receptor participation in important visceral functions such as cardiovascular respiratory regulation has also been documented by other workers (Kennett et al. 1987; Meyer et al. 2006 ; Nalivaiko et al. 2005; Ogren et al. 2008; Popa et al. 2005; Schreiber et al. 1998; Ulak et al. 2010 ). The present study showed that the positive 5-HT1A cells were in the dorsal vagal nucleus, while 5-HT2A cells were in the solitary nucleus. Both are known as important areas for visceral function (Yew et al. 1990 ). Whether these 1A and 2A receptors are also involved in sleep apnea is still controversial (Sawaguchi et al. 2003) . On the other hand, the participation of serotonin-related cells in depression and suicide has been frequently suggested (see review Arango et al. 2002) . Past experiments have mostly been concerned with the cortex, e.g., in the prefrontal cortex (Lorke et al. 2006) , while the involvement of these diseases of the brainstem remains elusive. The presence of 5-HT1A receptor positive cells in the pontile nucleus in this study is interesting because of the cerebellar connections (Brodal 1981) . It is highly likely that at least 5-HT1A plays a role in the corticalcerebellar-vestibular functions. Apoptosis in cells with different transmitters in Alzheimer brainstem versus those of age-matched controls has been documented in the cerebral cortex in other studies (Li et al. 1997; Yew et al. 1999a, b) . In this study, decrease of serotonin receptor 1A and 2A receptor positive cells in the brainstem of these patients may also mean either cell death of specific types of neurons or downregulation of receptor production. Thus, the present study further strengthens the need to review the brainstem as vigorously as the cortex.
While 5-HT1A and 5-HT2A were observed in common regions like the periaqueductal gray, in the substantia nigra, the pontile nucleus, and the dorsal raphe, they might exist individually and not together, e.g., 5-HT1A in the dorsal vagal nucleus and 5-HT2A in the trigeminal nucleus and the solitary nucleus. There were suggestion where 1A and 2A were always present together in the cortex (Yuen et al. 2008) ; this, however, might not be the case in our study, as either 5-HT1A or 5-HT2A receptors might be present solely in some nuclei. The decrease of serotonin 5-HT1A receptors in nuclei like the pontile nuclei, the dorsal vagal nucleus, and the dorsal raphe nucleus has pointed to cerebellar (ponto cerebellar link) and autonomic (vagal) disturbances and also disturbances leading to insomnia and depression (dorsal raphe). The presence of the serotonin receptors in the trigeminal nucleus is interesting, perhaps equivalent to the pain pathway as documented in the substantia gelatinosa of the spinal cord (Abe et al. 2009 ). The decrease of 5-HT2A receptors in the sensory trigeminal nucleus might point to derangement of facial sensation. These downregulations elicited in the brainstem might combine with those of the cortex to form a group of complex syndromes that could become apparent in the Alzheimer patients. This is something we should note with care. Related studies on receptors 5-HT1A and 1B on the brainstem nuclei have been documented in the postnatal rat: The positive sites were mainly in the raphe nucleus, nucleus ambiguus, hypoglossal nucleus, and the reticular, and solitary nucleus (Liu and Wong-Riley 2010) . In this adult human study, we have additional positive locations, e.g., pontile nucleus, vagal nucleus, and trigeminal nucleus. This may be due to the differences between adult versus postnatal or simply the differences in species. Finally, although many transmitters have been documented in the human brainstem (Li et al. 2007; Lorke et al. 2003; Shen et al. 1989; Tiu et al. 1993; Wai et al. 2004; Yew et al. 1990 Yew et al. , 1991 Yew et al. , 1992 Yew et al. , 1996 Yew et al. , 1999c Yew and Chan 1999) , results have been scattered along the cortex and different nuclei, which has made correlation difficult. For example, it had been documented that many sites in the medulla contained catecholaminergic neurons (Lorke et al. 2003) and NPY positive cells (Wai et al. 2004) , while the midbrain raphe nucleus and reticular formation contained serotonin cells (Shen et al. 1989) . However, attempting to colocalize specific types of neurons in this study with different transmitters resulted in finding that only the cholinergic neurons have serotonin 5-HT1A receptors, while on the other hand, GABAergic fibers innervated 5-HT2A positive neurons. This latter interaction of GABA and 5-HT2A receptors has been suggested in the cortex (Yan 2002) . Since this is the first study in this area, the interaction of 5-HT receptors with different neurons certainly needs to be pursued in greater detail in future research.
There had been very few studies on 5-HT1A and 5-HT2A receptors in Alzheimer's disease. Salmon (2007) reported that in these patients, there was a loss of 5-HT2A receptors in the association cortex and 5-HT1A receptors in the hippocampus. He suggested that these might be related to hyperactivity, aggression, and memory lost (Salmon 2007) . Our study here pointed out that there were 5-HT1A and 5-HT2A changes in the brainstem as well. Costall et al. (1990) reported that 5-TH1A receptors were related to cholinergic projections. In this study, we found that cholinergic neurons themselves had serotonin receptors (see above). Rocchi et al. (2003) reported that 5-HT2A polymorphosis were related to psychosis. Ramanathan and Glatt (2009) suggested that at least 5-HT2A receptors were involved in psychosis and delusion. Similar changes in isolated mice showed reduction of 5-HT receptors in prefrontal cortex, hippocampus, hypothalamus, and midbrain and those associated with hyperactive and aggressive behavior (Bibancos et al. 2007) . It is hoped that in the future there are more studies in these directions.
